EANM guidelines on the use of [ 18 F]FDG PET/CT in diagnosis, staging, prognostication, therapy assessment, and restaging of plasma cell disorders.

Authors :: Nanni C
Deroose CM
Balogova S
Lapa C
Withofs N
Subesinghe M
Jamet B
Zamagni E
Ippolito D
Delforge M
Kraeber-Bodéré F
Source :: European journal of nuclear medicine and molecular imaging [Eur J Nucl Med Mol Imaging] 2024 Aug 29. Date of Electronic Publication: 2024 Aug 29.
Publication Year :: 2024
Publisher :: Ahead of Print
Abstract: We provide updated guidance and standards for the indication, acquisition, and interpretation of [ <superscript>18</superscript> F]FDG PET/CT for plasma cell disorders. Procedures and characteristics are reported and different scenarios for the clinical use of [ <superscript>18</superscript> F]FDG PET/CT are discussed. This document provides clinicians and technicians with the best available evidence to support the implementation of [ <superscript>18</superscript> F]FDG PET/CT imaging in routine practice and future research.<br /> (© 2024. The Author(s).)

Full Text Access

Tools